Found 30 matching trials
SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN) PHASE1 The study will be conducted in adult patients with Chemotherapy-induced Per...
Show More Location
Emeritis Research
Learn More & Join Trial
Study to Evaluate Erlotinib With or Without SNDX-275 (Entinostat) in the Treatment of Patients With Advanced NSCLC PHASE1 The purpose of this study is to evaluate the safety and efficacy of entinos...
Show More Location
HOPE (Hematology Oncology Physicians & Extenders)
Learn More & Join Trial
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer PHASE1 The purpose of this study is to evaluate the safety and tolerability and ov...
Show More Location
Chan Soon-Shiong Institute for Medicine
Learn More & Join Trial
E. Coli Nissle in Oncology PHASE3 In patients with gastric or colorectal cancers, where a treatment with 5-Fl...
Show More Location
Klinikum Ludwigsburg
Learn More & Join Trial
S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo PHASE3 RATIONALE: Acetyl-L-carnitine may prevent or lessen neuropathy caused by ch...
Show More Location
Providence Cancer Center at Providence Hospital
Learn More & Join Trial
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208) PHASE3 This study will compare the safety and efficacy of a three-day oral aprepit...
Show More Location
Multiple Locations
Learn More & Join Trial
Ketotifen: as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy N/A The objective of our study was to evaluate the expected cardioprotective ef...
Show More Learn More & Join Trial
A Multicenter, Randomized, Controlled Trial of SCH 619734 for the Treatment of Chemotherapy-Induced Nausea and Vomiting (Study P04351AM2)(COMPLETED) PHASE2 This is a Phase 2, randomized, multicenter, parallel-group, double-blind, p...
Show More Location
Multiple Locations
Learn More & Join Trial
First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma PHASE3 This is a phase 3, multicenter, randomized, double-blind, placebo controlle...
Show More Learn More & Join Trial
Coenzyme Q10 and Chemotherapeutic Toxicity in Breast Cancer Patients PHASE2 investigating the potential effect of Coenzyme Q10 in ameliorating and prev...
Show More Location
Damanhour Oncology Center
Learn More & Join Trial